Veterinary Medicine Information website

Equip FT vet. injektioneste, suspensio

Authorised
  • Influenza A virus, subtype H7N7, strain A/equine/Newmarket/77, Inactivated
  • Influenza A virus, subtype H3N8, strain A/equine/Borlange/91, Inactivated
  • Influenza A virus, subtype H3N8, strain A/equine/Kentucky/1/98, Inactivated
  • Tetanus toxoid
Download as PDF

Product identification

Medicine name:
Equip FT vet. injektioneste, suspensio
Active substance:
  • Influenza A virus, subtype H7N7, strain A/equine/Newmarket/77, Inactivated
  • Influenza A virus, subtype H3N8, strain A/equine/Borlange/91, Inactivated
  • Influenza A virus, subtype H3N8, strain A/equine/Kentucky/1/98, Inactivated
  • Tetanus toxoid
Target species:
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Influenza A virus, subtype H7N7, strain A/equine/Newmarket/77, Inactivated
    1.20
    log10 haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
  • Influenza A virus, subtype H3N8, strain A/equine/Borlange/91, Inactivated
    2.10
    log10 haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
  • Influenza A virus, subtype H3N8, strain A/equine/Kentucky/1/98, Inactivated
    2.40
    log10 haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
  • Tetanus toxoid
    70.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Available in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 13527
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 11/01/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 11/01/2024
Download